Ajooni Biotech Limited submitted a SEBI Regulation 74(5) compliance certificate for Q4 FY26 to NSE.
The certificate confirms dematerialization processes were completed correctly for the quarter ended March 31, 2026.
Cameo Corporate Services Limited issued the confirmation as the company's Registrar & Transfer Agent.
Securities were mutilated, cancelled, and register of members updated within stipulated timelines.